$4.48 Billion is the total value of HHLR ADVISORS, LTD.'s 60 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 175.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MSFT | Buy | MICROSOFT CORP | $253,136,775 | -2.1% | 801,700 | +5.6% | 5.65% | +2.7% |
| AMZN | Buy | AMAZON COM INC | $101,950,240 | +3118.4% | 802,000 | +3200.4% | 2.28% | +3297.0% |
| New | RAYZEBIO INC | $30,984,895 | – | 1,395,716 | +100.0% | 0.69% | – | |
| Buy | ROIVANT SCIENCES LTD | $28,599,403 | +442.0% | 2,448,579 | +367.8% | 0.64% | +470.5% | |
| New | NEUMORA THERAPEUTICS INC. | $23,977,306 | – | 1,699,313 | +100.0% | 0.54% | – | |
| New | SAGIMET BIOSCIENCES INC | $12,755,978 | – | 1,449,543 | +100.0% | 0.28% | – | |
| SE | New | SEA LTDsponsord ads | $7,682,460 | – | 174,800 | +100.0% | 0.17% | – |
| PACB | New | PACIFIC BIOSCIENCES CALIF IN | $7,672,748 | – | 918,892 | +100.0% | 0.17% | – |
| TSLA | New | TESLA INC | $7,506,600 | – | 30,000 | +100.0% | 0.17% | – |
| BZ | Buy | KANZHUN LIMITEDsponsored ads | $1,876,529 | +1.4% | 123,700 | +0.6% | 0.04% | +7.7% |
| AMAM | New | AMBRX BIOPHARMA INCsponsored ads | $364,953 | – | 31,735 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 20 | Q3 2023 | 26.0% |
| JD.COM INC | 20 | Q3 2023 | 13.1% |
| IQIYI INC | 20 | Q3 2023 | 12.3% |
| MONDELEZ INTL INC | 20 | Q3 2023 | 5.9% |
| KINIKSA PHARMACEUTICALS LTD | 20 | Q3 2023 | 1.6% |
| SOHU COM LTD | 20 | Q3 2023 | 0.6% |
| PINDUODUO INC | 19 | Q3 2023 | 16.1% |
| GOSSAMER BIO INC | 19 | Q3 2023 | 2.3% |
| BRIDGEBIO PHARMA INC | 18 | Q3 2023 | 3.4% |
| MELCO RESORTS AND ENTMT LTD | 18 | Q1 2023 | 2.8% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
| On Holding AG | February 14, 2023 | 5,468,504 | 1.9% |
| Root, Inc. | February 14, 2023 | 138,977 | 1.5% |
| Yatsen Holding Ltd | February 14, 2023 | 300,560,602 | 19.1% |
| iQIYI, Inc. | July 11, 2022 | 149,075,912 | 5.0% |
| Apellis Pharmaceuticals, Inc. | February 14, 2022 | ? | ? |
| Beam Therapeutics Inc. | February 14, 2022 | ? | ? |
| Futu Holdings Ltd | February 14, 2022 | 2 | - |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 4 | 2024-02-01 |
| 13F-HR | 2023-11-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.